Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer

Surgery

Volumn 136, Issue 2, 2004, Pages 199-204

  Pin, Richard H ^a   Reinblatt, Maura ^a   Fong, Yuman ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; ONCOLYTIC VIRUS;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; SIMPLEXVIRUS; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 3843099218     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.04.016     Document Type: Article

References (23)

1. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515
2. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Bean J.M., Prosnitz L.R., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943
3. Dachs G.U., Greco O., Tozer G.M. Targeting cancer with gene therapy using hypoxia as a stimulus. Methods Mol Med. 90:2004;371-388
4. Bush R.S., Jenkin R.D., Allt W.E., Beale F.A., Bean H., Dembo A.J., et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl. 37:1978;302-306
5. Tannock I., Guttman P. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br J Cancer. 43:1981;245-248
6. Coradini D., Pellizzaro C., Speranza A., Daidone M.G. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. Cell Mol Life Sci. 61:2004;76-82
7. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 269:1994;23757-23763
8. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 12:1992;5447-5454
9. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 92:1995;5510-5514
10. Goldberg M.A., Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem. 269:1994;4355-4359
11. Kooby D.A., Carew J.F., Halterman M.W., Mack J.E., Bertino J.R., Blumgart L.H., et al. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J. 13:1999;1325-1334
12. Wong R.J., Patel S.G., Kim S., DeMatteo R.P., Malhotra S., Bennett J.J., et al. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther. 12:2001;253-265
13. Toda M., Rabkin S.D., Martuza R.L. Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther. 9:1998;2177-2185
14. Mineta T., Rabkin S.D., Martuza R.L. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 54:1994;3963-3966
15. Mineta T., Rabkin S.D., Yazaki T., Hunter W.D., Martuza R.L. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med. 1:1995;938-943
16. Post D.E., Van Meir E.G. Generation of bidirectional hypoxia/HIF- responsive expression vectors to target gene expression to hypoxic cells. Gene Ther. 8:2001;1801-1807
17. Markert J.M., Medlock M.D., Rabkin S.D., Gillespie G.Y., Todo T., Hunter W.D., et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7:2000;867-874
18. Yoon S.S., Nakamura H., Carroll N.M., Bode B.P., Chiocca E.A., Tanabe K.K. An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J. 14:2000;301-311
19. Thelander L., Reichard P. Reduction of ribonucleotides. Annu Rev Biochem. 48:1979;133-158
20. Hughes A.L. Origin and evolution of viral interleukin-10 and other DNA virus genes with vertebrate homologues. J Mol Evol. 54:2002;90-101
21. Shibata T., Giaccia A.J., Brown J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7:2000;493-498
22. Vaupel P., Schlenger K., Knoop C., Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51:1991;3316-3322
23. Hockel M., Schlenger K., Knoop C., Vaupel P. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 51:1991;6098-6102